Guardian Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Sell
12,425
-1,750
-12% -$377K 2.02% 15
2026
Q1
$3.08M Buy
14,175
+30
+0.2% +$6.66K 2.43% 13
2025
Q4
$3.23M Sell
14,145
-100
-0.7% -$22.8K 2.52% 12
2025
Q3
$3.3M Sell
14,245
-50
-0.3% -$10.2K 2.8% 9
2025
Q2
$2.65M Sell
14,295
-2,105
-13% -$391K 2.67% 9
2025
Q1
$3.44M Sell
16,400
-1,401
-8% -$272K 2.89% 8
2024
Q4
$3.16M Sell
17,801
-450
-2% -$82.7K 2.26% 10
2024
Q3
$3.6M Sell
18,251
-1,475
-7% -$275K 3.1% 8
2024
Q2
$3.38M Sell
19,726
-500
-2% -$82.8K 2.42% 12
2024
Q1
$3.68M Sell
20,226
-1,895
-9% -$327K 2.96% 10
2023
Q4
$3.43M Sell
22,121
-700
-3% -$102K 2.89% 9
2023
Q3
$3.4M Buy
22,821
+27
+0.1% +$3.96K 3.09% 9
2023
Q2
$3.07M Sell
22,794
-6,723
-23% -$986K 2.61% 10
2023
Q1
$3.19M Buy
29,517
+5,700
+24% +$871K 2.39% 11
2022
Q4
$3.85M Hold
23,817
3.64% 6
2022
Q3
$3.2M Sell
23,817
-3,200
-12% -$459K 3.24% 5
2022
Q2
$4.14M Hold
27,017
3.6% 4
2022
Q1
$4.38M Buy
27,017
+600
+2% +$87.2K 3.4% 5
2021
Q4
$3.58M Hold
26,417
2.49% 10
2021
Q3
$2.85M Sell
26,417
-2,900
-10% -$331K 2.1% 18
2021
Q2
$3.3M Sell
29,317
-200
-0.7% -$22.5K 2.26% 16
2021
Q1
$3.19M Hold
29,517
2.27% 14
2020
Q4
$3.16M Hold
29,517
2.4% 11
2020
Q3
$2.58M Hold
29,517
2.25% 18
2020
Q2
$2.9M Sell
29,517
-1,299
-4% -$114K 2.63% 10
2020
Q1
$2.35M Sell
30,816
-200
-0.6% -$17K 2.4% 14
2019
Q4
$2.75M Hold
31,016
2.18% 17
2019
Q3
$2.35M Sell
31,016
-100
-0.3% -$6.86K 2.09% 15
2019
Q2
$2.26M Hold
31,116
1.97% 18
2019
Q1
$2.51M Sell
31,116
-33
-0.1% -$2.7K 2.17% 18
2018
Q4
$2.87M Buy
31,149
+1,033
+3% +$90.8K 2.65% 13
2018
Q3
$2.85M Buy
30,116
+200
+0.7% +$19K 2.51% 15
2018
Q2
$2.77M Buy
29,916
+500
+2% +$48.8K 2.65% 13
2018
Q1
$2.78M Sell
29,416
-500
-2% -$54.9K 2.97% 12
2017
Q4
$2.89M Sell
29,916
-1,500
-5% -$141K 3.05% 12
2017
Q3
$2.79M Hold
31,416
3.08% 13
2017
Q2
$2.28M Sell
31,416
-1,300
-4% -$87.4K 2.52% 14
2017
Q1
$2.13M Buy
32,716
+8,600
+36% +$541K 2.32% 16
2016
Q4
$1.51M Buy
24,116
+1,700
+8% +$104K 1.74% 21
2016
Q3
$1.39M Hold
22,416
1.54% 25
2016
Q2
$1.39M Buy
22,416
+200
+0.9% +$12.2K 1.54% 25
2016
Q1
$1.27M Sell
22,216
-2,000
-8% -$111K 1.45% 27
2015
Q4
$1.44M Buy
24,216
+700
+3% +$40.3K 1.54% 26
2015
Q3
$1.3M Sell
23,516
-1,484
-6% -$96.6K 1.44% 27
2015
Q2
$1.71M Buy
25,000
+5,000
+25% +$326K 1.91% 20
2015
Q1
$1.16M Hold
20,000
1.29% 33
2014
Q4
$1.64M Hold
20,000
1.72% 21
2014
Q3
$1.03M Hold
20,000
1.19% 38
2014
Q2
$1.13M Hold
20,000
1.23% 37
2014
Q1
$1.03M Hold
20,000
1.19% 38
2013
Q4
$1.06M Hold
20,000
1.18% 38
2013
Q3
$900K Hold
20,000
1.22% 38
2013
Q2
$831K Buy
+20,000
New +$875K 1.2% 38

Other funds holding ABBV

Guardian Investment Management's ABBV Position: Q2 2026 in Review

Guardian Investment Management reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $377K and leaving 12,425 shares worth $3.13M. The position accounts for 2.02% of the portfolio, ranked #15.

Guardian Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.38M in Q1 2022. 1,757 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guardian Investment Management held 12,425 shares of AbbVie worth $3.13M as of Q2 2026.
  • Guardian Investment Management sold 1,750 AbbVie shares in Q2 2026, an estimated $377K.
  • AbbVie made up 2.02% of Guardian Investment Management's portfolio in Q2 2026, its #15 holding.
  • Guardian Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Guardian Investment Management's AbbVie position peaked at $4.38M in Q1 2022.
  • 1,757 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.